CASE REPORT
Bacillary angiomatosis by Bartonella quintana in HIV-infected patient: molecular confirmed case in Iran
 
More details
Hide details
1
Department of Infectious Diseases, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
 
2
Department of Epidemiology and Biostatistics, Research Center for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran
 
3
National Reference Laboratory for Plague, Tularemia and Q Fever, Research Center for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Akanlu, Kabudar Ahang, Hamadan, Iran
 
4
Iranian Research Center for HIV/AIDS, Iranian Institute for Reduction of High-Risk Behaviors, Tehran University of Medical Sciences, Tehran, Iran
 
5
Imam Hossein Hospital, Karaj, Alborz, Iran
 
6
Department of Surgery, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
 
7
Department of Internal Medicine, Imam Khomeini Hospital, Tehran University of Medical Science, Tehran, Iran
 
 
Submission date: 2020-11-04
 
 
Final revision date: 2020-12-19
 
 
Acceptance date: 2021-03-02
 
 
Publication date: 2021-06-30
 
 
HIV & AIDS Review 2021;20(2):147-150
 
KEYWORDS
TOPICS
ABSTRACT
Bartonella is an infrequent yet important pathogen in immunocompromised patients. Bartonella infections can cause serious morbidity and mortality in people living with human immunodeficiency virus (PLWH), particularly those with advanced immunosuppression. The  prevalence of  clinically evident Bartonella infections among PLWH is relatively low. Here, we reported a bacillary angiomatosis (BA) case in a homeless HIV-positive patient. A 31-year-old man with acquired immunodeficiency syndrome (AIDS) and advanced immunosuppression, who had discontinued antiretroviral therapy (ART) one year ago, referred to the hospital. At the admission, he had nausea, vomiting, anorexia, weight loss, occasional sputum cough, subjective fevers, and multiple skin lesions. Lesions’ biopsies were non-diagnostic for routine bacterial, tuberculosis, and fungal infection. However, the diagnosis of Bartonella quintana was confirmed by serum polymerase chain reaction (PCR). After receiving a long course of antibiotic therapy, skin lesions resolved. The patient had a favorable outcome with supportive care and continuation of ART and doxycycline. While easily treated, an infection due to Bartonella may be clinically unrecognized, if skin lesions are absent or overlooked, and microbiologically unrecognized, if appropriate protocols are not followed. Because the fever caused by Bartonella infection is easily treated, it is essential that suspected clinical signs of Bartonella infection in immunocompromised hosts should be reported to the microbiology laboratory. Bartonella quintana infection can result in a broad range of often non-specific clinical manifestations; therefore, case patients must be evaluated for suspected bacteremia, and clinical wariness is required for diagnosis.
 
REFERENCES (19)
1.
Baranowski K, Huang B. Cat Scratch Disease. StatPearls Publishing, Treasure Island 2020. Available at: https://www.ncbi.nlm.nih.gov/b... [Updated: 23.06.2020].
 
2.
Boulouis HJ, Chang CC, Henn JB, Kasten RW, Chomel BB. Factors associated with the rapid emergence of zoonotic Bartonella infections. Vet Res 2005; 36: 383-410.
 
3.
Adal KA, Cockerell CJ, Petri Jr WA. Cat scratch disease, bacillary angiomatosis, and other infections due to Rochalimaea. N Engl J Med 1994; 330: 1509-1515.
 
4.
Koehler JE, Sanchez MA, Garrido CS, et al. Molecular epidemiology of Bartonella infections in patients with bacillary angiomatosis-.
 
5.
peliosis. N Engl J Med 1997; 337: 1876-1883.
 
6.
Maurin M, Birtles R, Raoult D. Current knowledge of Bartonella species. Eur J Clin Microbiol Infect Dis 1997; 16: 487-506.
 
7.
Rigopoulos D, Paparizos V, Katsambas A. Cutaneous markers of HIV infection. Clin Dermatol 2004; 22: 487-498.
 
8.
Piérard-Franchimont C, Quatresooz P, Piérard GE. Skin diseases associated with Bartonella infection: facts and controversies. Clin Dermatol 2010; 28: 483-488.
 
9.
Kaplan JE, Benson C, Holmes KK, Brooks JT, Pau A, Masur H; Centers for Disease Control and Prevention (CDC), National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents. MMWR Recomm Rep 2009; 58 (RR-4): 1-207; quiz CE1-4.
 
10.
Maggi RG, Kempf VA, Chomel BB, Breitschwerdt EB. Bartonella. In: Manual of Clinical Microbiology. 10th ed. American Society of Microbiology 2011; 786-798.
 
11.
Rolain JM, Brouqui P, Koehler JE, Maguina C, Dolan MJ, Raoult D.
 
12.
Recommendations for treatment of human infections caused by Bartonella species. Antimicrob Agents Chemother 2004; 48: 1921-1933.
 
13.
Espy MJ, Uhl JR, Sloan LM, Buckwalter SP, Jones MF, Vetter EA,.
 
14.
Yao JD, Wengenack NL, Rosenblatt JE, Cockerill F3, Smith TF.
 
15.
Real-time PCR in clinical microbiology: applications for routine.
 
16.
laboratory testing. Clin Microbiol Rev 2006; 19: 165-256.
 
17.
Mateen FJ, Newstead JC, McClean KL. Bacillary angiomatosis in an HIV-positive man with multiple risk factors: a clinical and epidemiological puzzle. Can J Infect Dis Med Microbiol 2005; 16:.
 
18.
249-252.
 
19.
Gasquet S, Maurin M, Brouqui P, Lepidi H, Raoult D. Bacillary angiomatosis in immunocompromised patients. AIDS 1998; 12: 1793-1803.
 
eISSN:1732-2707
ISSN:1730-1270
Journals System - logo
Scroll to top